These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Efficacy and safety of microfoam sclerotherapy in a patient with Klippel-Trenaunay syndrome and a patent foramen ovale. Redondo P, Bastarrika G, Sierra A, Martínez-Cuesta A, Cabrera J. Arch Dermatol; 2009 Oct; 145(10):1147-51. PubMed ID: 19841402 [Abstract] [Full Text] [Related]
23. [Coma following ethanol sclerotherapy]. Blasco V, Pellegrini L, Visintini P, Leone M, Antonini F, Albanèse J, Martin C. Presse Med; 2008 Apr; 37(4 Pt 1):614-7. PubMed ID: 18178055 [Abstract] [Full Text] [Related]
30. Sclerotherapy treatment of a large venous malformation invading the bladder wall related to Klippel-Trenaunay syndrome. Foster L, Karunanithy N, Thurairaja R. BMJ Case Rep; 2020 Dec 21; 13(12):. PubMed ID: 33370935 [Abstract] [Full Text] [Related]
32. Direct percutaneous ethanol sclerotherapy for treatment of a recurrent venous malformation in the periorbital region. Lee CH, Chen SG. ANZ J Surg; 2004 Dec 21; 74(12):1126-7. PubMed ID: 15574162 [No Abstract] [Full Text] [Related]
37. Treatment Outcomes and Effects of Ethanol Sclerotherapy on Systemic Coagulation Profile of Patients with Venous Malformation. Yu MW, Han YY, Wang Q, Wang M, Chen Y, Yuan SM. Ann Vasc Surg; 2022 Sep 21; 85():268-275. PubMed ID: 35395373 [Abstract] [Full Text] [Related]